2010
DOI: 10.1371/journal.pbio.1000571
|View full text |Cite
|
Sign up to set email alerts
|

How Can Vaccines Against Influenza and Other Viral Diseases Be Made More Effective?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
19
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 17 publications
(32 reference statements)
0
19
0
Order By: Relevance
“…Such competition results in the immune system preferentially using memory cells in responding to the presentation of an immunogen immunoreactive with the memory B-cell receptors (33). Besides providing a rapid secondary immune response to reinfections with same pathogen, this mechanism is the basis for the phenomenon of original antigenic sin (OAS) (48), also known as heterologous immunity (49) or repertoire freeze (50).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Such competition results in the immune system preferentially using memory cells in responding to the presentation of an immunogen immunoreactive with the memory B-cell receptors (33). Besides providing a rapid secondary immune response to reinfections with same pathogen, this mechanism is the basis for the phenomenon of original antigenic sin (OAS) (48), also known as heterologous immunity (49) or repertoire freeze (50).…”
Section: Discussionmentioning
confidence: 99%
“…Immune responses r i are stimulated by jth variants at rates g j,i x j , where g j,i represents the probability of stimulation of immune response r i by variant x j . It is assumed that x j preferentially stimulates preexisting immune responses capable of binding to x j with a relatively high affinity (33), and thus g j,i is calculated as…”
Section: Modelmentioning
confidence: 99%
“…Due to antigenic variability and immune evasion of circulating strains, yearly vaccinations (based on current strain in the population) need to be performed. [25][26][27] A universal influenza vaccine has been an important objective for decades and there have been many failed attempts to design such a vaccine.…”
Section: Antigenically Variable Pathogensmentioning
confidence: 99%
“…Cross-reactivity has been suggested as a mechanism to evade the immune response in a number of human pathogens, including influenza virus (19), Streptococcus pneumoniae (20), and schistosomiasis (21). In this study, we describe a model that combines variant switching with cross-reactive immune responses to determine the most effective and likely manner for producing chronic asymptomatic infections despite a limited var gene repertoire.…”
mentioning
confidence: 99%